Petros Pharmaceuticals, Inc. (PTPI) Gross margin 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) gross margin by fiscal year — reported gross profit divided by reported revenue.
76.3%FY2024 · since FY2020: 57.7% → 76.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 76.3% | +4.3 pp |
| FY2023 | 72.0% | +10.2 pp |
| FY2022 | 61.8% | -17.7 pp |
| FY2021 | 79.5% | +21.9 pp |
| FY2020 | 57.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Net marginPTPI Gross profitPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →